We are live on ! Find out more
BG

Bollard Group Portfolio holdings

AUM $3.39B
1-Year Est. Return 1.06%
This Fund
S&P 500
This Quarter Est. Return
-1.19%
1 Year Est. Return
-1.06%
3 Year Est. Return
+72.63%
5 Year Est. Return
+112.03%
10 Year Est. Return
+415.67%
AUM
$4.26B
AUM Growth
-$118M
Cap. Flow
+$932M
Cap. Flow %
21.89%
Top 10 Hldgs %
73.27%
Holding
299
New
5
Increased
187
Reduced
15
Closed
28

Top Buys

Rank Stock Value
1
CAT icon
Caterpillar
CAT
+$4.87M
2
SCCO icon
Southern Copper
SCCO
+$4.86M
3
OKE icon
Oneok
OKE
+$3.88M
4
MSFT icon
Microsoft
MSFT
+$3.87M
5
EPD icon
Enterprise Products Partners
EPD
+$3.66M

Top Sells

Rank Stock Value
1
BSX icon
Boston Scientific
BSX
+$35.8M
2
LLY icon
Eli Lilly
LLY
+$32.9M
3
IT icon
Gartner
IT
+$18.4M
4
BNTX icon
BioNTech
BNTX
+$2.75M
5
ENTG icon
Entegris
ENTG
+$1.85M

Sector Composition

Rank Sector Weight
1 Healthcare 51.19%
2 Technology 7.33%
3 Energy 7.29%
4 Utilities 4.99%
5 Consumer Discretionary 4.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TDW icon
251
Tidewater
TDW
$3.91B
$5K ﹤0.01%
100
-100
-50% -$5.48K
KDP icon
252
Keurig Dr Pepper
KDP
$40.4B
$4K ﹤0.01%
141
– –
VMEO
253
DELISTED
Vimeo
VMEO
$4K ﹤0.01%
524
– –
WAB icon
254
Wabtec
WAB
$51.1B
$4K ﹤0.01%
20
– –
PFE icon
255
Pfizer
PFE
$140B
$3K ﹤0.01%
122
+2
+2% +$49
FLR icon
256
Fluor
FLR
$7.29B
$2K ﹤0.01%
45
– –
OGN icon
257
Organon & Co
OGN
$3.55B
$2K ﹤0.01%
184
– –
ANGI icon
258
Angi Inc
ANGI
$224M
$1K ﹤0.01%
88
– –
ICE icon
259
Intercontinental Exchange
ICE
$82.4B
$1K ﹤0.01%
8
– –
MYO icon
260
Myomo
MYO
$37.5M
$1K ﹤0.01%
1,570
– –
NKE icon
261
Nike
NKE
$61.9B
$1K ﹤0.01%
19
– –
NOC icon
262
Northrop Grumman
NOC
$77B
$1K ﹤0.01%
1
– –
REZI icon
263
Resideo Technologies
REZI
$5.23B
$1K ﹤0.01%
16
– –
RGP icon
264
Resources Connection
RGP
$129M
$1K ﹤0.01%
178
+3
+2% +$15
ROST icon
265
Ross Stores
ROST
$76.6B
$1K ﹤0.01%
8
– –
RUSHA icon
266
Rush Enterprises Class A
RUSHA
$5.95B
$1K ﹤0.01%
20
– –
ABEO icon
267
Abeona Therapeutics
ABEO
$345M
– –
-49,393
Closed -$281K
ACVA icon
268
ACV Auctions
ACVA
$1.35B
– –
-27,131
Closed -$440K
BNTX icon
269
BioNTech
BNTX
$22.6B
– –
-25,780
Closed -$2.75M
CHRW icon
270
C.H. Robinson
CHRW
$22B
$0 ﹤0.01%
2
– –
CLDX icon
271
Celldex Therapeutics
CLDX
$2.77B
– –
-19,627
Closed -$399K
CNTA
272
DELISTED
Centessa Pharmaceuticals
CNTA
– –
-100,362
Closed -$1.32M
COGT icon
273
Cogent Biosciences
COGT
$6.79B
– –
-105,059
Closed -$754K
HELP
274
Cybin Inc
HELP
$472M
– –
-156,954
Closed -$1.32M
D icon
275
Dominion Energy
D
$62.5B
– –
-198
Closed -$11K
8 9 10
11
12

Similar funds

BCM
Becker Capital Management Portland, Oregon $3.4B AUM 24.68% 1-Year Est. Return
OAM
Oberweis Asset Management Lisle, Illinois $3.39B AUM 105.5% 1-Year Est. Return
MCM
Marsico Capital Management Denver, Colorado $3.4B AUM 51.58% 1-Year Est. Return
DFO
Duquesne Family Office New York $3.38B AUM 61.92% 1-Year Est. Return
VFCM
Valley Forge Capital Management Miami, Florida $3.38B AUM 15.93% 1-Year Est. Return
EFM
E Fund Management Guangzhou, China $3.37B AUM
WS
Wedbush Securities Los Angeles, California $3.43B AUM 24.13% 1-Year Est. Return
DIA
Dana Investment Advisors Waukesha, Wisconsin $3.35B AUM 29.65% 1-Year Est. Return

Bollard Group's Q3 2025 Portfolio in Review

As of Q3 2025, Bollard Group held 299 positions worth $4.26B, down 2.7% from $4.37B the previous quarter. Its ten largest holdings account for 73% of the portfolio.

Bollard Group deployed $932M of net new capital in Q3 2025, opening 5 new positions and adding to 187 existing holdings. Its largest new stake was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.

By sector, the portfolio is most concentrated in Healthcare at 51% of assets, down from 56% a quarter earlier, followed by Technology and Energy.

On the sell side, the largest reduction was Boston Scientific, an estimated $35.8M trimmed.

  • Bollard Group's largest Q3 2025 buy was Tortoise North American Pipeline ETF: 68,861 shares worth $2.51M.
  • Bollard Group added most to Caterpillar in Q3 2025, an estimated $4.87M increase.
  • Bollard Group's biggest Q3 2025 reduction was Boston Scientific, cutting an estimated $35.8M.
  • Bollard Group fully exited BioNTech in Q3 2025, selling an estimated $2.75M.
  • Bollard Group's ten largest holdings make up 73% of its $4.26B portfolio in Q3 2025.
  • Bollard Group opened 5 new positions and closed 28 in Q3 2025.
  • Bollard Group's portfolio value fell 2.7% quarter-over-quarter to $4.26B.

Based on Bollard Group's 13F filing for Q3 2025, filed 14 Nov 2025.